Stocks
Longeveron Sets August 2026 ELPIS II Readout, Adopts Asset-Light Model
Longeveron (LGVN) targets an August 2026 readout for its ELPIS II study, simultaneously shifting to an asset-light partnering model under new leadership....
Financial Team 677 articles
Stocks
Corn Futures See Mixed Close Amid Ethanol Production Gains
Corn futures closed with mixed results as improved ethanol production data emerged. The national average cash corn price saw a slight uptick.
Stocks
Lulu’s Projects 2026 Positive Adjusted EBITDA, Outlines $2.0M-$2.5M Capex
Lulu's Fashion Lounge Holdings, Inc. anticipates achieving positive adjusted EBITDA in 2026, supported by a planned capital expenditure of $2.0M-$2.5M.
Stocks
Black Rock Coffee Bar Confirms 2026 Revenue and Store Growth Targets
Black Rock Coffee Bar reaffirmed its 2026 outlook, projecting $255M-$257M in revenue and 36 new store openings, while closely monitoring Phoenix market...
Stocks
TELA Bio Projects 8% Revenue Growth for 2026, Guides Q2 at $20M
TELA Bio (TELA) forecasts at least 8% revenue growth for 2026 and guides Q2 revenue to about $20.0 million, citing early success...
Stocks
Lean Hog Futures Decline Sharply on Tuesday
Lean hog futures saw widespread losses of up to $1.80 on Tuesday, with only the May contract posting a slight gain. Key...
Stocks
AudioEye Sets $12M 2026 EBITDA Target, Boosts Agentic AI Focus
AudioEye targets at least $12 million in 2026 adjusted EBITDA, driven by an extended focus on agentic AI and the April 2027...
Stocks
Dollar Gains on Weak Stocks, Oil Price Jump, Inflation Data
The dollar index advanced +0.34% on Tuesday, propelled by surging crude oil prices, renewed geopolitical concerns, and stronger-than-expected US inflation data. Stock...
Stocks
LENZ Therapeutics Reports Q1 2026 Performance, Targets 15,000 HCPs
LENZ Therapeutics delivered Q1 2026 results consistent with expectations, achieving $1.9 million in net revenue and approximately 25,000 prescriptions. The company also...